Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Inc.

RCKT | NASDAQ
Chart Builder DCF Calculator
$3.40
+$0.13 (+3.98%)
Sep 22, 2026, 11:22 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-223.12M -258.75M -245.6M -221.86M -169.07M -139.7M
Depreciation & Amortization
11.03M 9.38M 7.1M 6.27M 5.37M 1.15M
Stock-Based Compensation
37.06M 43.92M 39.41M 31.01M 29.24M 18.57M
Other Working Capital
-8.3M 1.92M 13.46M -3.6M 1.44M 4.01M
Other Non-Cash Items
-6.68M -6.19M -9.28M 370K 13.53M 29.32M
Deferred Income Tax
n/a n/a n/a n/a 3.15M 999K
Change in Working Capital
-8.3M 1.92M 13.46M 6.08M -3.39M 15.03M
Operating Cash Flow
-190.01M -209.72M -194.92M -178.14M -121.16M -74.64M
Capital Expenditures
-440K -5.86M -16.47M -8.62M -7.72M -29.06M
Cash Acquisitions
n/a n/a n/a 42.73M 95K 8.45M
Purchase of Investments
-276.55M -245.89M -390.92M -376.33M -245.88M -209.34M
Sales Maturities Of Investments
380.76M 383.45M 309.33M 272.89M 272.44M 141.81M
Other Investing Acitivies
n/a n/a n/a n/a -95K -8.45M
Investing Cash Flow
103.77M 131.71M -98.07M -69.33M 18.85M -96.59M
Debt Repayment
n/a n/a 139K 172K 201K 5.56M
Common Stock Repurchased
-67K n/a n/a -47K n/a -72K
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
215K n/a -132K -172K -201K -3.85M
Financial Cash Flow
148K 185.74M 208.4M 155.29M 37.68M 282.99M
Net Cash Flow
-86.1M 107.72M -84.58M -92.18M -64.63M 111.76M
Free Cash Flow
-190.45M -215.59M -211.39M -186.76M -128.88M -103.7M
Adj. Free Cash Flow
-227.51M -259.51M -250.79M -217.77M -158.12M -122.27M
Maintenance CapEx
-440K -5.86M -7.1M -6.27M -5.37M -1.15M
Growth CapEx
n/a n/a -9.37M -2.35M -2.34M -27.91M
Owner Earnings
-190.45M -215.59M -202.01M -184.41M -126.54M -75.79M

© 2026 bestshares.com. All rights reserved.